Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
Not yet recruiting · NCT06633718 · Registry updated 2024-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI | Infections, Intraabdominal Infections | Not yet recruiting | Phase 3 | 2024-10-09 | NCT06633718 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Provincial People's Hospital | Hangzhou | China | 48 |